Find important information for patients about once-daily IMBRUVICA®.
Location: Netherlands, North Brabant, Hulten
Investors 1
| Date | Name | Website |
| - | Aisling Ca... | aislingcap... |
Mentions in press and media 8
| Date | Title | Description | Category | Author | Source |
| 12.06.2021 | JOHNSON &a... | GLOW study presented as a late... | - | - | marketscre... |
| 15.01.2019 | China’s Be... | In MCL, the company has a Phas... | - | - | medcitynew... |
| 21.11.2016 | High price... | Pills used to treat a form of ... | - | - | statnews.c... |
| 25.09.2015 | Former Pha... | This new round, ostensibly a S... | - | - | medcitynew... |
| - | Biomarker ... | Chronic lymphocytic leukemia (... | - | - | statnews.c... |
| - | China’s Be... | A Chinese firm has received br... | - | - | medcitynew... |
| - | Examining ... | Chronic lymphocytic leukemia (... | - | - | statnews.c... |
| - | Former Pha... | Bay area immuno-oncology start... | - | - | medcitynew... |